MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/15504263.2025.2557191

Медицинская библиотека · Journal of dual diagnosis · 2025

Association of Lifetime Psychiatric Comorbidity and Current Substance Use in Methadone-Treated Individuals with Opioid Use Disorders.

Barbaglia M Gabriela, Molero-Calafell Javier, Angulo-Brunet Ariadna, Alcaraz Saül, Bartroli Montse, Mestre-Pintó Joan I, Methadone Study Group

СтатьяПеревод в очереди

Аннотация

OBJECTIVE

The primary objective of this study was to assess the association between psychiatric comorbidity and current substance use in a sample of patients with opioid use disorder (OUD) receiving opioid agonist treatment (OAT) with methadone in outpatient drug treatment centers. Secondary objectives were: (a) to examine the associations between socio-demographic and clinical characteristics and specific substance use (opioids, cocaine, alcohol, cannabis), and (b) to identify the socio-demographic and clinical factors associated with substance use based on lifetime psychiatric comorbidity status.

METHODS

A convenience sample of 588 patients (20% women; Mage 48.4) was recruited from eight outpatient drug treatment centers in Catalonia (Spain), which offer a comprehensive treatment approach. Dual diagnosis was assessed using the Dual Disorder Screening Interview (DDSI), and self-reported substance use (opioids, cocaine, cannabis, and alcohol) was evaluated through a specific questionnaire. Poisson regression with a log link was used to test five models adjusted for sociodemographic, clinical, and treatment variables.

RESULTS

A total of 63.5% of the patients tested positive for a lifetime dual diagnosis, and 83.5% reported substance use in the past month. No increased likelihood of opioid, cocaine, or alcohol use was observed among those with a lifetime dual diagnosis, except for cannabis use (PR = 1.29).

CONCLUSIONS

Psychiatric comorbidity was not associated with current substance use in methadone-treated patients, except cannabis use. The observed patterns may be influenced by the pharmacological effects of methadone and the comprehensive treatment approach provided to patients.

Для цитирования: Barbaglia M Gabriela, Molero-Calafell Javier, Angulo-Brunet Ariadna, Alcaraz Saül, Bartroli Montse, Mestre-Pintó Joan I, Methadone Study Group. Association of Lifetime Psychiatric Comorbidity and Current Substance Use in Methadone-Treated Individuals with Opioid Use Disorders.. Journal of dual diagnosis. 2025. DOI: 10.1080/15504263.2025.2557191.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.